$PURE News

PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results

PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoY

PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results

PURE Bioscience Q2 EPS $(0.01), Same YoY, Sales $443.000K Up From $391.000K YoY

PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results

PURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY

PURE Bioscience, Inc. Announces Leadership Promotions

PURE Bioscience Reports Fiscal 2025 Financial Results

PURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY

PURE Bioscience Partners with Bonsai for Direct-to-Customer Sales

PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results

PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $491.00K Up From $441.00K YoY

PURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry

PURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results

PURE Bioscience Q2 2025 EPS ($0.01) In-Line YoY; Revenue $391K Up From $325K YoY.

PURE Bioscience Q2 2025 EPS ($0.01) In-Line YoY; Revenue $391K Up From $325K YoY.

PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company

PURE Bioscience Unveils New Brand Identity

PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results

PURE Bioscience Announces Distribution Agreement with AFCO, a Zep Company